Corticosteroid Use in Patients with Crohn's Disease Initiating Vedolizumab in the Real-World Setting

被引：0
|
作者：
Sands, Bruce [1 ]
Khalid, Javaria [2 ]
Barocas, Morris [3 ]
Raluy-Callado, Mireia [4 ]
Merinopoulou, Evie [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Takeda Dev Ctr Europe Ltd, London, England
[3] Takeda Pharmaceut Inc, Deerfield, IL USA
[4] Evidera, London, England
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-064
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [41] REAL-WORLD TRENDS IN CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS INITIATING VEDOLIZUMAB OVER TIME IN ISRAEL
    Weil, C.
    Chodick, G.
    Shalev, V
    Demuth, D.
    Petrakis, I
    Ben Baruch, O.
    Tsukinovsky, S.
    Yarden, A.
    VALUE IN HEALTH, 2018, 21 : S142 - S142
  • [42] The Use of Vedolizumab in Patients With Concomitant Cirrhosis and Crohn's Disease
    Kapila, NIkhil
    Flocco, Gianina
    Shen, Bo
    Esfeh, Jamak M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1169 - S1169
  • [43] Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn's disease patients (EVOLVE) in Canada: Interim results
    Bressler, B.
    Greenup, A. -J.
    Bassel, M.
    Stein, D.
    Soni, M.
    Radulescu, G.
    Neish, C.
    Khalid, J. M.
    Demuth, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S382 - S382
  • [44] REAL-WORLD EVIDENCE OF VEDOLIZUMAB THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: FECAL CALPROTECTIN A VALID BIOMARKER OF MUCOSAL INFLAMMATION
    Cicerone, C.
    Luppino, I.
    Erboso, M.
    Paese, P.
    Leo, P.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E239 - E239
  • [45] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients
    Garg, Rajat
    Aggarwal, Manik
    Butler, Robert
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 3138 - 3147
  • [46] REAL-WORLD OUTCOMES FOR UPADACITINIB IN CROHN'S DISEASE PATIENTS AT A SINGLE CENTER
    Chugh, Rishika
    Terdiman, Jonathan P.
    El-Nachef, Najwa
    Wolf, Libby
    Mahadevan, Uma
    GASTROENTEROLOGY, 2022, 162 (07) : S990 - S990
  • [47] Effectiveness and safety of ustekinumab in patients with Crohn's disease: a real-world experience
    Mohammad, D.
    Alshahrani, A.
    Bao, Y.
    Alramdan, R.
    Rajani, A.
    Chauhan, U.
    Salena, B.
    Tse, F.
    Greenwald, E.
    Albashir, S.
    Halder, S.
    Armstrong, D.
    Marshall, J.
    Narula, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S426 - S426
  • [48] Real World Ustekinumab Use in Pediatric Patients With Crohn's Disease
    Ritter, Timothy E.
    Sarles, Harry E.
    Whitney, Annette E.
    Kim-Romo, Dawn N.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1056 - S1056
  • [49] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
    Rajat Garg
    Manik Aggarwal
    Robert Butler
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Digestive Diseases and Sciences, 2022, 67 : 3138 - 3147
  • [50] Transmural healing in Crohn's disease: Real-world insights from the SUNRISE study on vedolizumab using intestinal ultrasonography
    Carter, D.
    Fiorino, G.
    Biedermann, P.
    Cassanelli, F.
    Meyer, M.
    Novak, K. L.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1559 - i1560
12345